Skin Squamous Cell Carcinoma — Trials

Skin Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

211 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 90
Recruiting: 48
Ph III recruiting: 4
Growth YoY: —
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 53.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 101–107 of 107 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05741073	Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC	recruiting	—	1,300	EuMelaReg gGmbHINDUSTRY	1	Mar 12, 2025	clinicaltrials
NCT03212404	Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers	active not recruiting	Phase 1	272	Checkpoint Therapeutics, Inc.INDUSTRY	9	Feb 3, 2025	clinicaltrials